Join
Live feed
·
PRReleasevia Quantisnow
Prime Medicine Inc. logo

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

ByQuantisnow·Wall Street's wire, on your screen.
PRME· Prime Medicine Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PRME (Prime Medicine Inc.) and more on Quantisnow.